Taeniasis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Disease Ontology: ¹¹ A parasitic helminthiasis infectious disease that has material basis in Taenia solium or has material basis in Taenia saginata, which are transmitted by ingestion of undercooked contaminated meat.

MalaCards based summary: Taeniasis, also known as infection by taeniarhynchus saginatus, is related to hymenolepiasis and enterobiasis. An important gene associated with Taeniasis is MT-CO1 (Mitochondrially Encoded Cytochrome C Oxidase I), and among its related pathways/superpathways are Innate Immune System and MIF Mediated Glucocorticoid Regulation. The drugs Praziquantel and Dexamethasone acetate have been mentioned in the context of this disorder. Affiliated tissues include brain, salivary gland and small intestine, and related phenotypes are homeostasis/metabolism and endocrine/exocrine gland

Wikipedia: ⁷⁵ Taeniasis is an infection within the intestines by adult tapeworms belonging to the genus Taenia. There... more...

Sources

Related Diseases for Taeniasis

Diseases related to Taeniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 827)

#	Related Disease	Score	Top Affiliating Genes
1	hymenolepiasis	31.0	STH MT-CO1
2	enterobiasis	30.9	STH MT-CO1 IL5 IL4
3	cysticercosis	30.9	TLR4 TACSTD2 STH MT-ND5 MT-ND1 MT-CO1
4	diphyllobothriasis	30.6	MT-ND5 MT-ND1 MT-CO1
5	cystic echinococcosis	30.3	MT-ND5 MT-ND1 MT-CO1 IL4 IL10 CES2
6	ancylostomiasis	30.3	MT-ND5 MT-ND1 MT-CO1 IL5
7	metagonimiasis	30.2	MT-CO1 CTSL
8	pediculus humanus capitis infestation	30.2	MT-CYB MT-CO1
9	echinococcosis	30.2	TNF TLR4 MT-CO1 IL6 IL5 IL10
10	trichuriasis	30.1	TNF STH IL13 IL10
11	alveolar echinococcosis	30.0	MT-ND1 MT-CO1 IL5 IL4 IL10 CES2
12	hypereosinophilic syndrome	30.0	IL5 IL4 IL2 IL13 IL10
13	ileus	30.0	TNF IL6 IL10
14	ascaris lumbricoides infection	30.0	STH MT-ND1 IL5 IL4 IL13 IL10
15	giardiasis	29.9	STH IL10 CD8A CD4 ALB
16	paragonimiasis	29.8	STH MT-CO1 IL5 IL13 CTSL
17	trichinosis	29.8	TNF IL6 IL5 IL4 IL13 IL10
18	intracranial hypertension	29.7	TNF IL6 ALB
19	duodenal ulcer	29.7	TNF TLR4 IL6 IL10
20	gastritis	29.6	TNF TLR4 IL6 IL4 IL10
21	fascioliasis	29.6	MT-ND1 MT-CO1 IL4 IL10 CTSL ALB
22	strongyloidiasis	29.5	STH MT-CO1 IL5 IL4 IL13 IL10
23	clonorchiasis	29.5	TNF STH MT-CO1 IL2 IL10 CTSL
24	intestinal obstruction	29.5	TNF IL6 CD8A ALB
25	schistosomiasis	29.4	TNF IL5 IL4 IL2 IL13 IL10
26	salmonellosis	29.4	TNF TLR4 IL6 IL4 IL10 CD8A
27	amebiasis	29.4	TNF TLR4 IL6 IL4 IL10 CTSL
28	chagas disease	29.3	TNF TLR4 IL6 IL4 IL2 IL10
29	deficiency anemia	29.3	TNF IL6 IL2 IL10 CD8A CD4
30	appendicitis	29.2	TNF TLR4 IL6 IL2 IL10 ALB
31	dengue disease	29.2	TNF IL6 IL10 CD8A CD4 ALB
32	intestinal schistosomiasis	28.9	TNF STH MT-CO1 IL5 IL4 IL2
33	severe combined immunodeficiency	28.9	TNF IL6 IL5 IL4 IL2 IL13
34	diarrhea	28.8	TNF TLR4 IL6 IL5 IL2 IL13
35	allergic disease	28.7	TNF IL6 IL5 IL4 IL2 IL13
36	leishmaniasis	28.4	TNF TLR4 IL6 IL5 IL4 IL2
37	filarial elephantiasis	28.3	TNF TLR4 STH MT-CO1 IL5 IL4
38	filariasis	28.0	TNF TLR4 STH MT-CO1 IL6 IL5
39	parasitic helminthiasis infectious disease	27.7	TNF TLR4 STH MT-ND1 MT-CO1 IL6
40	mesocestoidiasis	10.4	MT-ND1 MT-CO1
41	echinostomiasis	10.4	MT-ND1 MT-CO1
42	oesophagostomiasis	10.4	MT-CYB MT-CO1
43	congenital nystagmus 1	10.3	MT-ND1 MT-CYB
44	severe congenital neutropenia 1	10.3	MT-ND5 MT-ND1
45	gnathomiasis	10.3	STH MT-CO1
46	acute cervicitis	10.3	IL10 CD4
47	parathyroid oncocytic adenoma	10.3	MT-ND1 MT-CYB MT-CO1
48	dracunculiasis	10.3	STH MT-CYB MT-CO1
49	polycystic echinococcosis	10.3	MT-ND1 MT-CO1 CES1
50	hilar lung neoplasm	10.3	CD8A CD4

Graphical network of the top 20 diseases related to Taeniasis:

Sources

Symptoms & Phenotypes for Taeniasis

MGI Mouse Phenotypes related to Taeniasis:

⁴⁵ (show all 11)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	homeostasis/metabolism	MP:0005376	10.28	ALB CD4 CES1 CTSL IL10 IL13
2	endocrine/exocrine gland	MP:0005379	10.18	ALB CD4 CD8A CES1 CTSL IL10
3	liver/biliary system	MP:0005370	10.16	ALB CES1 CTSL IL10 IL2 IL4
4	cellular	MP:0005384	10.13	ALB CD4 CD8A CTSL IL10 IL13
5	digestive/alimentary	MP:0005381	10.11	ALB CD4 CTSL IL10 IL13 IL2
6	neoplasm	MP:0002006	10.1	ALB IL10 IL2 IL5 IL6 TACSTD2
7	muscle	MP:0005369	10.08	ALB CTSL IL10 IL13 IL6 MT-CO1
8	immune system	MP:0005387	10.07	ALB CD4 CD8A CTSL IL10 IL13
9	hematopoietic system	MP:0005397	9.77	CD4 CD8A CES1 CES2 CTSL IL10
10	respiratory system	MP:0005388	9.76	IL10 IL13 IL2 IL4 IL5 IL6
11	integument	MP:0010771	9.4	CD4 CD8A CES1 CES2 CTSL IL10

Sources

Drugs & Therapeutics for Taeniasis

Drugs for Taeniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Praziquantel

Approved, Investigational, Vet_approved

Phase 3

55268-74-1

4891

2

Dexamethasone acetate

Approved, Investigational, Vet_approved

Phase 2, Phase 3

1177-87-3

3680

3

Dexamethasone

Approved, Investigational, Vet_approved

Phase 2, Phase 3

50-02-2

3003 5743

Synonyms:

[<sup>3</sup>H]-dexamethasone

16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol

16alpha -Methyl-9alpha -fluoroprednisolone

16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol

16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol

16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone

16alpha-Methyl-9alpha-fluoroprednisolone

16-alpha-Methyl-9-alpha-fluoroprednisolone

16a-Methyl-9a-fluoro-1-dehydrocortisol

16Α-methyl-9α-fluoro-1-dehydrocortisol

1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone

1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone

1-Dehydro-16a-methyl-9a-fluorohydrocortisone

1-Dehydro-16α-methyl-9α-fluorohydrocortisone

9a-Fluoro-16a-methylprednisolone

9a-Fluoro-16BETA-methylprednisolone

9alpha -Fluoro-16alpha -methylprednisolone

9alpha-Fluoro-16alpha-methylprednisolone

9alpha-Fluoro-16alpha-methyl-prednisolone

9-alpha-Fluoro-16-alpha-methylprednisolone

9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione

9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione

9-Fluoro-16-methylprednisolone

9Α-fluoro-16α-methylprednisolone

Adexone

Aeroseb-D

Aeroseb-dex

Ak dex OPH otic soln 0.1%

Alcon brand OF dexamethasone

alpha -Fluoro-16-alpha -methylcortisol

Anaflogistico

Aphtasolon

Aphthasolone

Apo-dexamethasone

Auxiron

Azimycin (veterinary)

Azium

Azium (veterinary)

Bisu DS

Calonat

Corson

Corsone

Cortisumman

DALALONE

Decacort

Decacortin

Decaderm

Decadron

Decadron Tablets, Elixir

Decadron®|desametasone|fluormethylprednisolone

DECADRON-75

DECADRON-LA

Decagel

Decaject

Decaject l.a.

Decaject-l.a.

Decalix

Decameth

Decasone

Decaspray

Dectancyl

Dekacort

Delta1-9alpha-Fluoro-16alpha-methylcortisol

Deltafluorene

Dergramin

Deronil

Desadrene

Desametasone

Desametasone [Dcit]

Desamethasone

Desameton

Deseronil

DEX

DEXA

Dexa mamallet

DEXACEN-4

Dexacidin

Dexacort

Dexacortal

Dexa-cortidelt

Dexacortin

Dexa-cortisyl

DEXACORTISYL

Dexadeltone

Dexafarma

DEXAFREE

DEXAIR

Dexalona

Dexaltin

Dexa-Mamallet

Dexametasona

Dexametasona [INN-Spanish]

Dexametasone

Dexameth

Dexamethansone

DEXAMETHASONE

Dexaméthasone

Dexamethasone acetate

Dexamethasone alcohol

Dexamethasone base

Dexamethasone intensol

DEXAMETHASONE METASULFOBENZOATE SODIUM

DEXAMETHASONE PALMITATE

Dexamethasone sodium phosphate

DEXAMETHASONE VALERATE

Dexamethasone-omega

Dexamethasonum

Dexamethasonum [INN-Latin]

Dexamethazone

Dexamonozon

Dexapolcort

Dexapos

Dexaprol

Dexa-scheroson

Dexa-sine

Dexason

Dexasone

Dexasone 0.5MG

Dexasone 0.75MG

Dexasone 4MG

Dexasporin

Dex-ide

Dexinolon

Dexinoral

Dexone

DEXONE 0.5

DEXONE 0.75

DEXONE 1.5

DEXONE 4

Dexonium

Dexpak

DEXSOL

Dextelan

DEXTENZA

DEXYCU KIT

Dezone

Dinormon

DROPODEX

DXM

DXM833

DXMS

ECR brand OF dexamethasone

Fluormethylprednisolone

Fluormone

Fluorocort

Fortecortin

Foy brand OF dexamethasone

Gammacorten

GPPE EAR SPY

Hexadecadrol

Hexadrol

Hexadrol elixir

Hexadrol Tablets

HL-Dex

ICN brand OF dexamethasone

IontoDex

Isopto-dex

ISV-305

KORTICO INJECTION

Lokalison F

Loverine

Luxazone

MARTAPAN

Maxidex

Maxidex ont 0.1%

Maxidex sus 0.1%

Maxitrol

Mediamethasone

Merck brand OF dexamethasone

Merz brand 1 OF dexamethasone

Merz brand 2 OF dexamethasone

Methylfluorprednisolone

Mexidex

Millicorten

Mymethasone

Naquasone (veterinary)

NEODECADRON

Neomycin and polymyxin b sulfates and dexamethasone

Neomycin and polymyxin b sulphates and dexamethasone

NSC 34521

NSC-34521

Ocu-trol

Oradexon

OTO-104

OTOMIZE

OZURDEX

Pet derm III

Pet-Derm Iii

PHL-Dexamethasone

PMS Dexamethasone elixir 0.5mg/5ML

PMS-Dexamethasone

Policort

Posurdex

Prednisolon F

Prednisolone F

Prodex

Sandoz dexamethasone

SK-Dexamethasone

SOFRADEX

SPERSADEX COMP

Spoloven

Sunia sol D

Superprednol

Tobradex

Tobramycin and dexamethasone

Tresaderm (veterinary)

Turbinaire

Visumetazone

4

Acetazolamide

Approved, Vet_approved

Phase 2, Phase 3

59-66-5, 1424-27-7

1986

Synonyms:

2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide

2-Acetylamino-1,3,4-thiadiazole-5-sulphonamide

5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide

5-ACETAMIDO-1,3,4-thiadiazole-2-sulphonamide

5-Acetylamino-1,3,4-thiadiazole-2-sulfonamide

5-Acetylamino-1,3,4-thiadiazole-2-sulphonamide

Acetadiazol

Acetamidothiadiazolesulfonamide

Acetamox

Acetazolam

Acetazolamid

Acetazolamida

ACETAZOLAMIDE

ACÉTAZOLAMIDE

ACETAZOLAMIDE 250MG

Acetazolamide apotex brand

Acetazolamide chiesi brand

Acetazolamide dioptic brand

Acetazolamide grin brand

Acetazolamide icn brand

Acetazolamide jumer brand

Acetazolamide llorens brand

Acetazolamide medphano brand

Acetazolamide novopharm brand

Acetazolamide orion brand

Acetazolamide Sodium

Acetazolamide sodium, (sterile)

Acetazolamide wassermann brand

Acetazolamide, monosodium salt

Acetazolamidum

Acetazolamine

Acetazoleamide

Acetozalamide

Ak zol

Ak-zol

AkZol

Apo acetazolamide

Apo-acetazolamide

ApoAcetazolamide

Apotex brand OF acetazolamide

Atenezol

Carbonic anhydrase inhibitor 6063

Chiesi brand OF acetazolamide

Ciba vision brand OF acetazolamide

Cidamex

Cyanamid brand OF acetazolamide preparation

Dazamide

Defiltran

Défiltran

Dehydratin

Diacarb

Diakarb

Diamox

Diamox Sequels

DIAMOX SR

Diamox®

Didoc

Diluran

Dioptic brand OF acetazolamide

Diuramid

Diuramide

Diureticum-Holzinger

Diuriwas

Diutazol

Donmox

Duiramid

Edemox

Eumicton

EYTAZOX

Fonurit

Glauconox

Glaupax

Glupax

Grin brand OF acetazolamide

Huma zolamide

Huma-zolamide

HumaZolamide

ICN brand OF acetazolamide

Jumer brand OF acetazolamide

L 579486

Lederle brand OF acetazolamide preparation

Llorens brand OF acetazolamide

Medphano brand OF acetazolamide

Monosodium salt acetazolamide

N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide

N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide

N-[5-(Aminosulphonyl)-1,3,4-thiadiazol-2-yl]acetamide

N-[5-(Aminosulphonyl)-1,3,5-thiadiazol-2-yl]acetamide

Natrionex

Nephramid

Nephramide

Novopharm brand OF acetazolamide

NSC-145177

Orion brand OF acetazolamide

Phonurit

Sk-Acetazolamide

Storz brand OF acetazolamide preparation

Storzolamide

Théraplix brand OF acetazolamide preparation

Vetamox

Wassermann brand OF acetazolamide

Whelehan brand OF acetazolamide preparation

Wyeth brand OF acetazolamide preparation

5

Benzocaine

Approved, Investigational

Phase 3

1994-09-7, 94-09-7

2337

6

Tannic acid

Approved

Phase 3

1401-55-4

16129878 16129778

7

Anti-Ulcer Agents

Phase 3

8

Antacids

Phase 3

9

Proton Pump Inhibitors

Phase 3

10

Antineoplastic Agents, Hormonal

Phase 2, Phase 3

11

Hormones

Phase 2, Phase 3

12

Hormone Antagonists

Phase 2, Phase 3

13

Antiemetics

Phase 2, Phase 3

14

Anticonvulsants

Phase 2, Phase 3

15

glucocorticoids

Phase 2, Phase 3

16

Anti-Inflammatory Agents

Phase 2, Phase 3

17

Gastrointestinal Agents

Phase 2, Phase 3

18

Carbonic Anhydrase Inhibitors

Phase 2, Phase 3

19

diuretics

Phase 2, Phase 3

20

Benzimidazole

Experimental, Investigational

Phase 1

51-17-2

5798

21

Niclosamide

Approved, Investigational, Vet_approved

50-65-7

4477

22

Phenytoin

Approved, Vet_approved

57-41-0

1775

Synonyms:

5,5-Diphenylhydantoin

5,5-Diphenylimidazolidine-2,4-dione

5,5-Diphenyl-imidazolidine-2,4-dione

5,5-Diphenyltetrahydro-1H-2,4-imidazoledione

5,5-Dwufenylohydantoina

Aleviatin

Antisacer

Auranile

Causoin

Citrullamon

Citrulliamon

Comital

Comitoina

Convul

Danten

Dantinal

Dantoinal

Dantoinal klinos

Dantoine

Denyl

Didan TDC 250

Difenilhidantoina

Difenilhidantoina [Spanish]

Difenin

Difetoin

Difhydan

Dihycon

Dihydan

Di-Hydan

Dihydantoin

DILABID

Di-Lan

DILANTIN

Dilantin acid

Dilantin®|Epanutin®|Phenytex®|phenytoin sodium

DILANTIN-125

DILANTIN-30

Dilantine

Dillantin

Dintoin

Dintoina

Diphantoin

Diphedal

Diphedan

Diphenat

Diphenin

Diphenine

Diphentoin

Diphentyn

Diphenylan

Diphenylan sodium

Diphenylhydantoin

Diphenylhydantoinate, sodium

Diphenylhydantoine [French]

Diphenylhydatanoin

Di-Phetine

Ditoinate

DPH

Ekko

Elepsindon

Enkelfel

Epamin

Epanutin

Epasmir 5

Epdantoin Simple

Epdantoine simple

Epelin

Epifenyl

Epihydan

Epilan

Epilan D

Epilan-D

Epilantin

Epinat

Epised

Eptal

Eptoin

Fenantoin

Fenidantoin s

Fenitoin

Fenitoina

Fenitoina [INN-Spanish]

Fentoin

Fenylepsin

Fenytoin Dak

Fenytoine

Gerot-epilan-D

Hidan

Hidantal

Hidantilo

Hidantina

Hidantina senosian

Hidantina vitoria

Hidantomin

Hindatal

Hydantal

Hydantin

Hydantoin

Hydantoinal

Hydantol

Ictalis simple

Idantoil

Idantoin

Iphenylhydantoin

Kessodanten

Labopal

Lehydan

Lepitoin

Lepsin

Mesantoin

Minetoin

Neos-Hidantoina

Neosidantoina

Novantoina

Novophenytoin

NSC-8722

Om hidantoina simple

Om-Hydantoine

Oxylan

Park davis brand OF phenytoin

Pfizer brand OF phenytoin

Phanantin

Phanatine

Phenatine

Phenatoine

Phenhydan

Phenhydanin

Phenitoin

Phentoin

PHENTYTOIN

PHENYTEK

PHENYTEX

Phenytoin

Phenytoin AWD

Phenytoin pfizer brand

Phenytoin phizer brand

Phenytoin sodium

Phenytoine

Phenytoine [INN-French]

Phenytoin-Gerot

Phenytoinum

Phenytoinum [INN-Latin]

Phizer brand OF phenytoin

Prompt Phenytoin Sodium

Ritmenal

Saceril

Sanepil

Silantin

Sinergina

SM-88 COMPONENT PHENYTOIN

Sodanthon

Sodantoin

Sodanton

Sodium diphenylhydantoinate

Solantin

Solantoin

Solantyl

Sylantoic

Tacosal

Thilophenyl

TOIN

Toin unicelles

Zentronal

Zentropil

23

Sodium Channel Blockers

24

Diuretics, Potassium Sparing

Interventional clinical trials:

(show all 26)

#	Name	Status	NCT ID	Phase	Drugs
1	Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole	Completed	NCT00441285	Phase 2, Phase 3	Praziquantel;Albendazole;ABZ Placebo;PZQ Placebo
2	A Clinical Trial to Study the Effects of Two Different Duration of Same Drug Albendazole in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Scan Head at the End of 6 Months	Completed	NCT02243644	Phase 3	7 days of albendazole 15 mg/kg/day;28 days of albendazole 15 mg/kg/day
3	Treatment of Intraparenchymal Neurocysticercosis: Effect of Increased Dosing of Corticosteroids on Seizure Frequency	Completed	NCT00290823	Phase 3	Albendazole;Dexamethasone;Omeprazole
4	A Pilot Study of Neurocysticercosis Treatment	Completed	NCT00283699	Phase 3	albendazole
5	Open Controled Randomized Pilot Study on the Use of Acetazolamide and Dexamethasone for the Acute Phase of Perilesional Edema in Calcified Neurocysticercosis	Terminated	NCT02945527	Phase 2, Phase 3	Acetazolamide;Dexamethasone
6	A Randomized Trial of Combined Albendazole Plus Praziquantel for Subarachnoid Cysticercosis of the Sylvian Fissure or the Basal Cisterns	Terminated	NCT02947581	Phase 3	Albendazole and praziquantel;Albendazole and praziquantel placebo
7	Randomized, Double Blind Comparison of Two Lenghts of Albendazole Therapy for Subarachnoid Cysticercosis	Withdrawn	NCT00133458	Phase 3	Albendazole
8	An Open-label Non-randomized Phase IIa Trial to Evaluate Safety of Early Intervention in Asymptomatic Subarachnoid Neurocysticercosis	Withdrawn	NCT03950037	Phase 2	Albendazole
9	PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28	Completed	NCT00526916	Phase 1	[C-11]PBR28
10	PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBR	Completed	NCT00527579	Phase 1	[F-18]FBR
11	A Randomized, Double-Blind Placebo-Controlled Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole	Completed	NCT02234570	Phase 1	Oxfendazole
12	Phase I Study of Oxfendazole (Toward the Treatment of Neurocysticercosis)	Withdrawn	NCT01584362	Phase 1	oxfendazole;placebo
13	Characteristics of Patients With Symptomatic Active Neurocysticercosis and Effect of Treatment on Symptoms, Lesions and Quality of Life in Resource-poor Rural Areas of Eastern Africa - TOPANA, a Multi-centre Prospective Cohort Study.	Unknown status	NCT03834337
14	Establishment and Application of a Taenia Solium Experimental Pig Infection Model and Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Eastern and Southern Provinces of Zambia	Unknown status	NCT03874689
15	The Burden of (Neuro)Cysticercosis Among People Living With HIV Compared With HIV-negative Individuals in the Rural Southern Highlands in Tanzania	Unknown status	NCT03851419
16	Targeted Screening for Taenia Solium Tapeworms	Completed	NCT01296958		Niclosamide
17	EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso	Completed	NCT03095339
18	Free Digital Health Education for Diseases of Public Health Importance (HIV, Tuberculosis and Taenia Solium Cysticercosis/Taeniosis) in Iringa, Tanzania	Completed	NCT03808597
19	Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis	Completed	NCT00004403		albendazole;dexamethasone;phenytoin
20	Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis	Completed	NCT00001912
21	Impact of Community-Led Total Sanitation on the Control of Taenia Solium and Soil Transmitted Helminths in the Eastern Province of Zambia	Completed	NCT01368354
22	Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature Review	Completed	NCT05010811
23	Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?	Recruiting	NCT02612896		Mass drug administration, praziquantel 10mg/kg
24	Natural History of Treated Neurocysticercosis and Long-Term Outcomes	Recruiting	NCT00001205
25	Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study	Not yet recruiting	NCT04706819
26	NACC 002: A Multicenter Prospective Natural History Study of Patients Presenting With Neurocysticercosis in North America	Terminated	NCT02233855

Search NIH Clinical Center for Taeniasis

Cochrane evidence based reviews: taeniasis

Sources

Genetic Tests for Taeniasis

Sources

Anatomical Context for Taeniasis

Organs/tissues related to Taeniasis:

MalaCards : Brain, Salivary Gland, Small Intestine, Tongue, Breast, Appendix, Colon

Sources

Publications for Taeniasis

Articles related to Taeniasis:

(show top 50) (show all 1090)

#	Title	Authors	PMID	Year
1	Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries-A pooled analysis. ⁶²	Stelzle D...Winkler AS	36342903	2022
2	Cysticercosis Infested Pectoralis Major Myocutaneous Flap Reconstruction: An Ethical Dilemma. ⁶²	Singh A...Bhinyaram	36452733	2022
3	Low Treatment Rates of Parasitic Diseases with Standard-of-Care Prescription Drugs in the United States, 2013-2019. ⁶²	Joo H...Stauffer WM	35995133	2022
4	Diagnosis of Schistosomiasis without a Microscope: Evaluating Circulating Antigen (CCA, CAA) and DNA Detection Methods on Banked Samples of a Community-Based Survey from DR Congo. ⁶²	Hoekstra PT...van Lieshout L	36288056	2022
5	Taeniasis Presenting as Motile Worms in the Stools: An Emerging but Neglected Parasitic Disease. ⁶²	Kandi V...Moses VK	36381783	2022
6	[Epidemic trend and control progress of taeniasis and cysticercosis in Henan Province]. ⁶²	Jiang TT...Chen WQ	36464252	2022
7	Disseminated Cysticercosis Masquerading as Mucocutaneous Nodules. ⁶²	Ratnika...Kulhari M	36304647	2022
8	Cysticercosis: A case of missed diagnosis. ⁶²	Goyal S...Goyal S	35302290	2022
9	Global variation in force-of-infection trends for human Taenia solium taeniasis/cysticercosis. ⁶²	Dixon MA...Basanez MG	35984416	2022
10	Neurocysticercosis Complicating Pregnancy. ⁶²	Cunningham FG...Twickler DM	35852272	2022
11	A Rare Case of Intestinal Taeniasis Presenting With Hematochezia and Iron Deficiency Anemia. ⁶²	Yuquimpo K...Bonino JA	36061255	2022
12	Application of Ziehl Neelsen Staining Method for Taenia spp. Eggs Differentiation. ⁶²	Machrumnizar M...Tan S	36466028	2022
13	Assessment of the Health-Related Quality of Life in Neurocysticercosis Patients in Hot Spot Areas - China, 2017-2018. ⁶²	Qian Y...Li S	35919479	2022
14	Knowledge, attitudes and practices related to Taenia solium cysticercosis and taeniasis in Tanzania. ⁶²	Nyangi C...Winkler AS	35692033	2022
15	Taenia solium taeniasis/cysticercosis in Guatemala: a prevalent public health problem? ⁶²	Hernandez-Chea RD...Fleury A	35657099	2022
16	Epidemiological status of bovine cysticercosis and human taeniasis in Eastern Ethiopia. ⁶²	Abera A...Assefa A	35402742	2022
17	CystiHuman: A model of human neurocysticercosis. ⁶²	Bonnet G...Cysticercosis Working Group in Peru	35587497	2022
18	New insights on the Taenia solium tapeworm using molecular tools: age-based human definitive host prevalence and deliberation on parasite life span. ⁶²	Li T...Ito A	34029172	2022
19	Mid-7th century BC human parasite remains from Jerusalem. ⁶²	Langgut D	34781239	2022
20	[Chronicle of a death foretold: the fateful fate of french tropical medicine disciplines and its consequences in the fight against health inequalities in Africa]. ⁶²	Millet P	35685835	2022
21	Implementation of Taenia solium control measures in Bali, Indonesia: Survey findings and a historical overview. ⁶²	Ito A...Budke CM	34968452	2022
22	Evaluation of Semi-Nested PCR Compared with Indirect-ELISA to Diagnose Human Fasciolosis. ⁶²	Alizadeh G...Rokni MB	35865068	2022
23	Advanced magnetic resonance imaging and spectroscopy in a case of neurocysticercosis from North America. ⁶²	Chawla S...Mohan S	34167362	2022
24	Epidemiology of floods in sub-Saharan Africa: a systematic review of health outcomes. ⁶²	Suhr F...Steinert JI	35144560	2022
25	Optimal control analysis of Taenia saginata bovine cysticercosis and human taeniasis. ⁶²	Mwasunda JA...Kuznetsov D	35028439	2022
26	Medicinal Plants Utilized for the Treatment of Gastrointestinal Parasitosis in Ethiopia. ⁶²	Aschale Y...Wubetu M	35340929	2022
27	[Effectiveness of training on Taenia solium taeniasis and cysticercosis control knowledge among medical professionals in disease-elimination pilot areas of Henan Province]. ⁶²	Chen WQ...Zhang HW	35128890	2022
28	Human health and economic impact of neurocysticercosis in Uganda. ⁶²	Dupont F...Devleesschauwer B	34861092	2022
29	Non-communicating hydrocephalus from pork tapeworm obstructing the foramina of Monro and its endoscopic management; a case report from Europe. ⁶²	Hamre F...Gutierrez-Gonzalez R	36248099	2022
30	Molecular Identification and Appraisal of the Genetic Variation of Taenia saginata in Central Regions of Vietnam. ⁶²	Tran Thi G...Casu M	35054461	2022
31	Intraventricular neurocysticercosis causing obstructing hydrocephalus. ⁶²	Perez A...Shamim S	35991743	2022
32	High prevalence of neurocysticercosis among patients with epilepsy in a tertiary care hospital of Assam, India. ⁶²	Devi KR...Narain K	35923269	2022
33	Stakeholders' Knowledge, Attitude, and Perceptions on the Control of Taenia solium in Kamuli and Hoima Districts, Uganda. ⁶²	Ngwili N...Roesel K	35464359	2022
34	Challenges in the Diagnosis of Taenia solium Cysticercosis and Taeniosis in Medical and Veterinary Settings in Selected Regions of Tanzania: A Cross-Sectional Study. ⁶²	Mlowe F...Mlangwa J	35815231	2022
35	The influence of eroding Djallonke genotype on the incidence of diseases and mortalities in Sahelian x Djallonke cross-bred sheep. ⁶²	Abdul-Rahman II...Niayele R	35079923	2022
36	Development and Accuracy Evaluation of Lateral Flow Immunoassay for Rapid Diagnosis of Schistosomiasis Mekongi in Humans. ⁶²	Rodpai R...Maleewong W	34981973	2022
37	The role of cooking practices in the transmission of the foodborne parasite Taenia solium: A qualitative study in an endemic area of Southern Tanzania. ⁶²	Moller KS...Magne J	36197909	2022
38	Non-local validated parametrization of an agent-based model of local-scale Taenia solium transmission in North-West Peru. ⁶²	Pizzitutti F...Cysticercosis Working Group in Peru	36166462	2022
39	Intestinal Perforation Due to Adult Tapeworm of Taenia: A Case Report and Review of the Literature. ⁶²	Bhandari R...Neumayr A	35125899	2022
40	Quantitative risk assessment of human Taenia solium exposure from consuming pork produced in Punjab, India. ⁶²	G K M...Brookes VJ	34402584	2021
41	Prevalence of meat-transmitted Taenia and Trichinella parasites in the Far East countries. ⁶²	Liu Y...Jin X	33768333	2021
42	[Effectiveness of health education interventions targeting taeniasis and cysticercosis among primary school students in disease-elimination pilot areas of Henan Province]. ⁶²	Deng Y...Zhao DY	35128888	2021
43	[Current status and challenges for taeniasis and cysticercosis control in China]. ⁶²	Guo ZY...Li SZ	35128885	2021
44	Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia. ⁶²	Saydam FN...Rodriguez-Morales AJ	34699956	2021
45	Vaccine for a neglected tropical disease Taenia solium cysticercosis: fight for eradication against all odds. ⁶²	Kaur R...Prasad A	34379534	2021
46	Case Report: Disseminated Cysticercosis due to Intentional Ingestion of Parasitic Worm Eggs for Weight Loss. ⁶²	Zhang HY...Xie MR	34844206	2021
47	Unusual oral expulsion of adult Taenia worm through vomiting. ⁶²	Raja SM	34745618	2021
48	Risk Factors for Bovine Cysticercosis in North-West Italy: A Multi-Year Case-Control Study. ⁶²	Rubiola S...Rambozzi L	34827781	2021
49	Validation of a spatial agent-based model for Taenia solium transmission ("CystiAgent") against a large prospective trial of control strategies in northern Peru. ⁶²	Pray IW...Cysticercosis Working Group in Peru.	34705827	2021
50	Parasitic zoonoses in the Roma population. ⁶²	Bajkovec L...Mrzljak A	34722364	2021

Sources

Genes for Taeniasis

Genes related to Taeniasis (0 elite genes):

(show all 23)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	MT-CO1	Mitochondrially Encoded Cytochrome C Oxidase I	Protein Coding	7.08	DISEASES inferred ¹⁴
2	TACSTD2	Tumor Associated Calcium Signal Transducer 2	Protein Coding	6.94	DISEASES inferred ¹⁴
3	MT-ND1	Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 1	Protein Coding	6.23	DISEASES inferred ¹⁴
4	STH	Saitohin	Protein Coding	6.07	DISEASES inferred ¹⁴
5	IL4	Interleukin 4	Protein Coding	6.04	DISEASES inferred ¹⁴
6	IL10	Interleukin 10	Protein Coding	5.97	DISEASES inferred ¹⁴
7	CD4	CD4 Molecule	Protein Coding	5.96	DISEASES inferred ¹⁴
8	CTSL	Cathepsin L	Protein Coding	5.7	DISEASES inferred ¹⁴
9	CES2	Carboxylesterase 2	Protein Coding	5.66	DISEASES inferred ¹⁴
10	MT-CYB	Mitochondrially Encoded Cytochrome B	Protein Coding	5.58	DISEASES inferred ¹⁴
11	IL5	Interleukin 5	Protein Coding	5.57	DISEASES inferred ¹⁴
12	MT-ND5	Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 5	Protein Coding	5.55	DISEASES inferred ¹⁴
13	CES1	Carboxylesterase 1	Protein Coding	5.43	DISEASES inferred ¹⁴
14	IL6	Interleukin 6	Protein Coding	5.38	DISEASES inferred ¹⁴
15	TNF	Tumor Necrosis Factor	Protein Coding	5.38	DISEASES inferred ¹⁴
16	IL13	Interleukin 13	Protein Coding	5.36	DISEASES inferred ¹⁴
17	CD8A	CD8a Molecule	Protein Coding	5.27	DISEASES inferred ¹⁴
18	TLR4	Toll Like Receptor 4	Protein Coding	5.24	DISEASES inferred ¹⁴
19	IL2	Interleukin 2	Protein Coding	5.24	DISEASES inferred ¹⁴
20	ALB	Albumin	Protein Coding	5.19	DISEASES inferred ¹⁴
21	TACR1	Tachykinin Receptor 1	Protein Coding	5.16	DISEASES inferred ¹⁴
22	SH3GLB1	SH3 Domain Containing GRB2 Like, Endophilin B1	Protein Coding	5.16	DISEASES inferred ¹⁴
23	TAC1	Tachykinin Precursor 1	Protein Coding	5.1	DISEASES inferred ¹⁴

Sources

Variations for Taeniasis

Sources

Expression for Taeniasis

Search GEO for disease gene expression data for Taeniasis.

Sources

Pathways for Taeniasis

Pathways related to Taeniasis according to GeneCards Suite gene sharing:

(show top 50) (show all 58)

#	Super pathways	Score	Top Affiliating Genes
1	Innate Immune System ⁶⁶ Show member pathways Immune System ⁶⁶ Neutrophil degranulation ⁶⁶	14	CD4 CD8A CTSL IL10 IL13 IL2
2	MIF Mediated Glucocorticoid Regulation ⁶⁴ Show member pathways all-trans-Retinoic Acid Signaling in Brain ⁶⁴ Endothelin-1 Signaling Pathway ⁶⁴ Glucocorticoid Receptor Signaling ⁶⁴ IL-6 Pathway ⁶⁴ MIF Regulation of Innate Immune Cells ⁶⁴ NFAT Signaling and Lymphocyte Interactions ⁶⁴ Overview of proinflammatory and profibrotic mediators ⁷⁴ PEDF Induced Signaling ⁶⁴ PGC1Alpha Pathway ⁶⁴ RAR-Gamma-RXR-Alpha Degradation ⁶⁴ STAT3 Pathway ⁶⁴	13.65	TNF TLR4 IL6 IL5 IL4 IL2
3	TGF-Beta Pathway ⁶⁴ Show member pathways JAK-STAT Pathway ⁶⁴ JNK Pathway ⁶⁴ MAPK Family Pathway ⁶⁴ Regulation of eIF4 and p70S6K ⁶⁴ SOCS Pathway ⁶⁴	13.56	TNF IL6 IL5 IL4 IL2 IL13
4	Akt Signaling ⁶⁴ Show member pathways p38 Signaling ⁶⁴ Tec Kinases Signaling ⁶⁴	13.44	TNF TLR4 IL6 IL5 IL4 IL2
5	Cytokine Signaling in Immune system ⁶⁶ Show member pathways Signaling by Interleukins ⁶⁶	13.35	TNF IL6 IL5 IL4 IL2 IL13
6	PAK Pathway ⁶⁴ Show member pathways Antioxidant Action of Vitamin-C ⁶⁴ Epithelial Adherens Junctions ⁶⁴	13.33	TNF IL6 IL5 IL4 IL2 IL13
7	Overview of interferons-mediated signaling pathway ⁷⁴ Show member pathways all-trans-Retinoic Acid Mediated Apoptosis ⁶⁴ Cytokine Network ⁶⁴ Immune response IFN alpha/beta signaling pathway ²² Interferon alpha/beta signaling ⁶⁶ Jak/STAT Signaling Pathway ⁶⁵ Regulation of IFNA/IFNB signaling ⁶⁶ Type III interferon signaling ⁷⁴	12.67	IL10 IL13 IL2 IL4 IL5 IL6
8	Immune response IL-23 signaling pathway ²² Show member pathways Angiopoietin receptor Tie2-mediated signaling ⁶¹ Angiopoietin-TIE2 Signaling ⁶⁴ Development Angiopoietin - Tie2 signaling ²² Development PDGF signaling via STATs and NF-kB ²² IL23-mediated signaling events ⁶¹ Immune response IL-10 signaling pathway ²² RAC1/PAK1/p38/MMP2 pathway ⁷⁴	12.62	TNF IL6 IL2 IL10 CD4
9	NF-kappaB Signaling ³	12.6	TNF IL4 IL2 IL10 CD8A
10	Bacterial infections in CF airways ²² Show member pathways Altered glycosylation of MUC1 in tumor microenvironment ⁷⁴ IL-1 beta-dependent CFTR expression ²² IL1-mediated signaling events ⁶¹ Immune response Bacterial infections in normal airways ²² Immune response TLR signaling pathways ²² NTHi-Induced Signaling ⁶⁴ Signal transduction through IL1R ⁷⁴	12.46	TNF TLR4 IL6 IL4 CTSL
11	Sudden infant death syndrome (SIDS) susceptibility pathways ⁷⁴	12.2	TNF IL6 IL13 IL10
12	Neuroinflammation and glutamatergic signaling ⁷⁴	12.16	TNF IL6 IL4 IL13 IL10
13	T-cell activation SARS-CoV-2 ⁷⁴ Show member pathways T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection ⁷⁴	12.13	TNF IL5 IL4 IL2 IL10 CD8A
14	MAPK Pathway ⁷⁰ Show member pathways Toll-like Receptor Pathway ⁷⁰	12.06	TLR4 IL5 IL2 IL13
15	Spinal cord injury ⁷⁴	12.06	TNF TLR4 IL6 IL4 IL2
16	IL12-mediated signaling events ⁶¹ Show member pathways Immune response IL-12-induced IFN-gamma production ²²	12.02	IL4 IL2 CD8A CD4
17	Interleukin-4 and Interleukin-13 signaling ⁶⁶	12.02	TNF IL6 IL4 IL13 IL10
18	IL27-mediated signaling events ⁶¹ Show member pathways IL12 signaling pathway ⁶⁷ Th1 Differentiation ⁶⁵	12	TNF TLR4 IL6 IL2 IL10 CD4
19	Hematopoietic Stem Cells and Lineage-specific Markers ⁶⁵	11.99	CD4 CD8A IL10 IL2 IL4 IL5
20	Allograft rejection ⁷⁴	11.96	TNF IL5 IL4 IL2 IL13 IL10
21	Th17 Differentiation ⁶⁵ Show member pathways IL-21 Signaling and its Primary Biological Effects in Different Immune Cell Types ⁶⁵	11.92	CD4 IL4 IL6 TLR4
22	Glucocorticoid receptor regulatory network ⁶¹	11.86	IL13 IL2 IL4 IL5 IL6
23	Acute viral myocarditis ⁷⁴	11.84	TLR4 IL6 IL2 IL10 CD4
24	Dendritic Cells Developmental Lineage Pathway ⁶⁵	11.82	TNF IL6 IL2 IL10 CD8A CD4
25	Th17 cell differentiation pathway ⁷⁴	11.79	IL6 IL4 IL2 CD4
26	AP-1 transcription factor network ⁶¹	11.79	IL6 IL5 IL4 IL2 IL10
27	Network map of SARS-CoV-2 signaling pathway ⁷⁴ Show member pathways Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex ⁷⁴	11.78	IL6 CD8A CD4
28	Burn wound healing ⁷⁴	11.77	TNF TLR4 IL6
29	Calcineurin-regulated NFAT-dependent transcription in lymphocytes ⁶¹ Show member pathways Calcium signaling in the CD4+ TCR pathway ⁶¹	11.76	TNF IL5 IL4 IL2
30	Extrafollicular B cell activation by SARS-CoV-2 ⁷⁴	11.76	TNF TLR4 IL6 IL4 IL2 IL10
31	Innate Lymphoid Cells Differentiation ⁶⁵	11.76	TNF IL5 IL4 IL2 IL13 IL10
32	Lung fibrosis ⁷⁴	11.74	TNF IL6 IL5 IL4 IL13
33	miRNAs involvement in the immune response in sepsis ⁷⁴	11.73	TNF TLR4 IL6 IL10
34	IL 10 signaling pathway ⁶⁷	11.72	TNF TLR4 IL6 IL10
35	Photodynamic therapy-induced NF-kB survival signaling ⁷⁴ Show member pathways Immune response MIF-mediated glucocorticoid regulation ²²	11.69	TNF IL6 IL2
36	IL4-mediated signaling events ⁶¹	11.67	IL5 IL4 IL10
37	NF-kB (NFkB) Pathway ⁶⁷	11.63	TNF TLR4 CD4
38	THC Differentiation Pathway ⁶⁴	11.61	TNF IL4 IL2 IL10 CD4
39	Non-genomic actions of 1,25 dihydroxyvitamin D3 ⁷⁴	11.59	TNF TLR4 IL6
40	Interleukin-10 signaling ⁶⁶	11.55	TNF IL6 IL10
41	Fibrin complement receptor 3 signaling pathway ⁷⁴	11.51	TNF TLR4 IL6
42	Th2 Differentiation ⁶⁵	11.51	IL5 IL4 IL2 IL13 IL10 CD4
43	IL-10 Pathway ⁶⁴	11.43	TNF TLR4 IL6 IL10
44	IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types ⁶⁵ Show member pathways IL-2 Signaling and its Primary Biological Effects in Different Immune Cell Types ⁶⁵	11.42	IL10 IL2 TNF
45	Development and heterogeneity of the ILC family ⁷⁴	11.4	IL13 IL4 IL5 IL6 TNF
46	Inflammatory response pathway ⁷⁴	11.38	IL5 IL4 IL2
47	Inflammatory bowel disease signaling ⁷⁴ Show member pathways Ulcerative colitis signaling ⁷⁴	11.33	TNF TLR4 IL6 IL5 IL4 IL2
48	IL12 signaling mediated by STAT4 ⁶¹	11.28	IL2 IL13 CD4
49	OX40 Pathway ⁶⁴	11.27	IL5 IL4 IL2 IL13 IL10
50	LDL- influence on CD14 and TLR4 ⁷⁴	11.15	TLR4 IL6 IL10

Sources

GO Terms for Taeniasis

Cellular components related to Taeniasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	respirasome	GO:0070469	8.92	MT-ND5 MT-ND1 MT-CYB MT-CO1

Biological processes related to Taeniasis according to GeneCards Suite gene sharing:

(show all 25)

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of DNA-binding transcription factor activity	GO:0051091	10.2	IL10 IL5 IL6 TNF
2	negative regulation of inflammatory response	GO:0050728	10.19	IL4 IL2 IL13 IL10
3	positive regulation of chemokine production	GO:0032722	10.09	TNF TLR4 IL6
4	negative regulation of endothelial cell apoptotic process	GO:2000352	10.04	IL10 IL13 IL4
5	liver regeneration	GO:0097421	10.03	TNF IL6 IL10
6	positive regulation of smooth muscle cell proliferation	GO:0048661	10.01	TNF TLR4 IL6 IL13
7	positive regulation of cytokine production involved in inflammatory response	GO:1900017	10	TNF TLR4 IL6
8	microglial cell activation	GO:0001774	9.99	TNF IL4 IL13
9	positive regulation of interleukin-10 production	GO:0032733	9.97	IL13 IL4 IL6 TLR4
10	positive regulation of tyrosine phosphorylation of STAT protein	GO:0042531	9.96	IL13 IL2 IL4 IL6 TNF
11	macrophage activation	GO:0042116	9.95	IL13 IL4 TLR4
12	positive regulation of macrophage activation	GO:0043032	9.93	IL10 IL13 TLR4
13	positive regulation of oxidative stress-induced neuron death	GO:1903223	9.92	TNF TLR4
14	positive regulation of receptor signaling pathway via JAK-STAT	GO:0046427	9.92	TNF IL6 IL5 IL10
15	positive regulation of mononuclear cell migration	GO:0071677	9.91	TNF IL4
16	negative regulation of cytokine production involved in immune response	GO:0002719	9.91	TNF IL10
17	positive regulation of MHC class II biosynthetic process	GO:0045348	9.91	TLR4 IL4 IL10
18	regulation of isotype switching	GO:0045191	9.88	IL4 IL10
19	electron transport coupled proton transport	GO:0015990	9.88	MT-ND5 MT-CO1
20	negative regulation of complement-dependent cytotoxicity	GO:1903660	9.85	IL4 IL13
21	positive regulation of B cell proliferation	GO:0030890	9.85	TLR4 IL5 IL4 IL2 IL13
22	positive regulation of plasma cell differentiation	GO:1900100	9.84	IL2 IL10
23	chronic inflammatory response to antigenic stimulus	GO:0002439	9.8	TNF IL10
24	positive regulation of immunoglobulin production	GO:0002639	9.65	IL10 IL13 IL2 IL5 IL6
25	immune response	GO:0006955	9.6	TNF TLR4 IL6 IL5 IL4 IL2

Molecular functions related to Taeniasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	growth factor activity	GO:0008083	9.65	IL6 IL5 IL4 IL2 IL10
2	methylumbelliferyl-acetate deacetylase activity	GO:0047374	9.56	CES2 CES1
3	cytokine activity	GO:0005125	9.47	TNF IL6 IL5 IL4 IL2 IL13
4	methyl indole-3-acetate esterase activity	GO:0080030	9.16	CES2 CES1

Sources

Sources for Taeniasis

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: TNS007 MIFTS: 50	Taeniasis Categories: Gastrointestinal diseases, Infectious diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables